A20-binding inhibitor of NF-κB (ABIN1) controls Toll-like receptor-mediated CCAAT/enhancer-binding protein β activation and protects from inflammatory disease

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 44, 2011, Pages

  Zhou, Jingran ^a   Wu, Ruiqiong ^a   High, Anthony A ^a   Slaughter, Clive A ^a,b   Finkelstein, David ^a   Rehg, Jerold E ^a   Redecke, Vanessa ^a   Häcker, Hans ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

A20 BINDING INHIBITOR OF NF KAPPAB; BINDING PROTEIN; CALGRANULIN A; CCAAT ENHANCER BINDING PROTEIN BETA; COLONY STIMULATING FACTOR; COLONY STIMULATING FACTOR 3; IMMUNOGLOBULIN; INDUCIBLE NITRIC OXIDE SYNTHASE; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; BONE MARROW CELL; CONTROLLED STUDY; DISEASE COURSE; GENETIC ASSOCIATION; GLOMERULONEPHRITIS; LEUKOCYTE; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEINURIA; PSORIASIS; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; BASE SEQUENCE; BONE MARROW CELLS; CCAAT-ENHANCER-BINDING PROTEIN-BETA; DNA PRIMERS; FETAL DEATH; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE; MICE, INBRED C57BL; NF-KAPPA B; PSORIASIS; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

MUS;

EID: 81055141569     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1106232108     Document Type: Article

References (49)

1. Medzhitov R (2008) Origin and physiological roles of inflammation. Nature 454:428-435.
2. Flesher DL, Sun X, Behrens TW, Graham RR, Criswell LA (2010) Recent advances in the genetics of systemic lupus erythematosus. Expert Rev Clin Immunol 6:461-479.
3. Roberson ED, Bowcock AM (2010) Psoriasis genetics: Breaking the barrier. Trends Genet 26:415-423.
4. Leadbetter EA, et al. (2002) Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 416:603-607. (Pubitemid 34406754)
5. Lande R, et al. (2007) Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature 449:564-569. (Pubitemid 47525141)
6. Gateva V, et al. (2009) A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus. Nat Genet 41:1228-1233.
7. Han JW, et al. (2009) Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus. Nat Genet 41:1234-1237.
8. Kawasaki A, et al. (2010) Association of TNFAIP3 interacting protein 1, TNIP1 with systemic lupus erythematosus in a Japanese population: A case-control association study. Arthritis Res Ther 12:R174-180.
9. Nair RP, et al., Collaborative Association Study of Psoriasis (2009) Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. Nat Genet 41:199-204.
10. Heyninck K, et al. (1999) The zinc finger protein A20 inhibits TNF-induced NF-kappaB-dependent gene expression by interfering with an RIP- or TRAF2-mediated transactivation signal and directly binds to a novel NF-kappaB-inhibiting protein ABIN. J Cell Biol 145:1471-1482. (Pubitemid 29310004)
11. Lee EG, et al. (2000) Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice. Science Y 289:2350-2354.
12. Boone DL, et al. (2004) The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses. Nat Immunol 5:1052-1060. (Pubitemid 41057725)
13. Häcker H, et al. (2000) Immune cell activation by bacterial CpG-DNA through myeloid differentiation marker 88 and tumor necrosis factor receptor-associated factor (TRAF) 6. J Exp Med 192:595-600. (Pubitemid 30666261)
14. Kawai T, Adachi O, Ogawa T, Takeda K, Akira S (1999) Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 11:115-122. (Pubitemid 29359962)
15. Häcker H, et al. (2006) Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6. Nature 439:204-207. (Pubitemid 43083141)
16. Takeuchi O, Akira S (2010) Pattern recognition receptors and inflammation. Cell 140:805-820.
17. Wang C, et al. (2001) TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 412:346-351. (Pubitemid 32694385)
18. Xu M, Skaug B, Zeng W, Chen ZJ (2009) A ubiquitin replacement strategy in human cells reveals distinct mechanisms of IKK activation by TNFalpha and IL-1beta. Mol Cell 36:302-314.
19. Wertz IE, et al. (2004) De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. Nature 430:694-699.
20. Oshima S, et al. (2009) ABIN-1 is a ubiquitin sensor that restricts cell death and sustains embryonic development. Nature 457:906-909.
21. Hemmi H, et al. (2000) A Toll-like receptor recognizes bacterial DNA. Nature 408:740-745. (Pubitemid 32015992)
22. Medzhitov R, Preston-Hurlburt P, Janeway CA, Jr. (1997) A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388:394-397. (Pubitemid 27334820)
23. Poltorak A, et al. (1998) Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: Mutations in Tlr4 gene. Science \ 282:2085-2088. (Pubitemid 29001265)
24. Bennett L, et al. (2003) Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med 197:711-723. (Pubitemid 36350866)
25. Hacbarth E, Kajdacsy-Balla A (1986) Low density neutrophils in patients with systemic lupus erythematosus, rheumatoid arthritis, and acute rheumatic fever. Arthritis Rheum 29:1334-1342. (Pubitemid 17214033)
26. Uematsu S, et al. (2007) The C/EBP beta isoform 34-kDa LAP is responsible for NF-IL-6-mediated gene induction in activated macrophages, but is not essential for intracellular bacteria killing. J Immunol 179:5378-5386.
27. Chang CJ, Shen BJ, Lee SC (1995) Autoregulated induction of the acute-phase response transcription factor gene, agp/ebp. DNA Cell Biol 14:529-537.
28. Frith MC, et al. (2004) Detection of functional DNA motifs via statistical over-representation. Nucleic Acids Res 32:1372-1381. (Pubitemid 38854738)
29. Descombes P, Schibler U (1991) A liver-enriched transcriptional activator protein, LAP, and a transcriptional inhibitory protein, LIP, are translated from the same mRNA. Cell 67:569-579. (Pubitemid 121001471)
30. Häcker H, et al. (1998) CpG-DNA-specific activation of antigen-presenting cells requires stress kinase activity and is preceded by non-specific endocytosis and endosomal maturation. EMBO J 17:6230-6240. (Pubitemid 28497796)
31. Graham RR, et al. (2008) Genetic variants near TNFAIP3 on 6q23 are associated with systemic lupus erythematosus. Nat Genet 40:1059-1061.
32. Musone SL, et al. (2008) Multiple polymorphisms in the TNFAIP3 region are independently associated with systemic lupus erythematosus. Nat Genet 40:1062-1064.
33. Plenge RM, et al. (2007) Two independent alleles at 6q23 associated with risk of rheumatoid arthritis. Nat Genet 39:1477-1482. (Pubitemid 350191346)
34. Thomson W, et al.; Wellcome Trust Case Control Consortium; YEAR Consortium (2007) Rheumatoid arthritis association at 6q23. Nat Genet 39:1431-1433. (Pubitemid 350191348)
35. Metcalf D (2008) Hematopoietic cytokines. Blood 111:485-491.
36. Lande R, et al. (2011) Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosus. Sci Transl Med 3:73ra19.
37. Garcia-Romo GS, et al. (2011) Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus. Sci Transl Med 3:73ra20.
38. Bogdan C (2001) Nitric oxide and the immune response. Nat Immunol 2:907-916.
39. Nagy G, et al. (2010) Central role of nitric oxide in the pathogenesis of rheumatoid arthritis and systemic lupus erythematosus. Arthritis Res Ther 12:210-215.
40. Soyfoo MS, Roth J, Vogl T, Pochet R, Decaux G (2009) Phagocyte-specific S100A8/A9 protein levels during disease exacerbations and infections in systemic lupus erythematosus. J Rheumatol 36:2190-2194.
41. Vogl T, et al. (2007) Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock. Nat Med 13:1042-1049. (Pubitemid 47517513)
42. Ramji DP, Foka P (2002) CCAAT/enhancer-binding proteins: Structure, function and regulation. Biochem J 365:561-575. (Pubitemid 34864439)
43. Nanda SK, et al. (2011) Polyubiquitin binding to ABIN1 is required to prevent autoimmunity. J Exp Med 208:1215-1228.
44. Ossipow V, Descombes P, Schibler U (1993) CCAAT/enhancer-binding protein mRNA is translated into multiple proteins with different transcription activation potentials. Proc Natl Acad Sci USA 90:8219-8223. (Pubitemid 23260887)
45. Lu YC, et al. (2009) Differential role for c-Rel and C/EBPbeta/delta in TLR-mediated induction of proinflammatory cytokines. J Immunol 182:7212-7221.
46. Kobayashi K, et al. (2002) IRAK-M is a negative regulator of Toll-like receptor signaling. Cell 110:191-202. (Pubitemid 34876547)
47. Pfeffer K, et al. (1993) Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 73:457-467. (Pubitemid 23143346)
48. Häcker H, et al. (1999) Cell type-specific activation of mitogen-activated protein kinases by CpG-DNA controls interleukin-12 release from antigen-presenting cells. EMBO J 18:6973-6982. (Pubitemid 30000450)
49. Stuehr DJ, Nathan CF (1989) Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J Exp Med 169:1543-1555. (Pubitemid 19126814)